Myristoylated alanine-rich C kinase substrate (MARCKS) is involved in myoblast fusion through its regulation by protein kinase Calpha and calpain proteolytic cleavage

The Biochemical Journal
Sandrine DulongP Cottin

Abstract

MARCKS (myristoylated alanine-rich C kinase substrate) is a major cytoskeletal protein substrate of PKC (protein kinase C) whose cellular functions are still unclear. However numerous studies have implicated MARCKS in the stabilization of cytoskeletal structures during cell differentiation. The present study was performed to investigate the potential role of Ca(2+)-dependent proteinases (calpains) during myogenesis via proteolysis of MARCKS. It was first demonstrated that MARCKS is a calpain substrate in vitro. Then, the subcellular expression of MARCKS was examined during the myogenesis process. Under such conditions, there was a significant decrease in MARCKS expression associated with the appearance of a 55 kDa proteolytic fragment at the time of intense fusion. The addition of calpastatin peptide, a specific calpain inhibitor, induced a significant decrease in the appearance of this fragment. Interestingly, MARCKS proteolysis was dependent of its phosphorylation by the conventional PKCalpha. Finally, ectopic expression of MARCKS significantly decreased the myoblast fusion process, while reduced expression of the protein with antisense oligonucleotides increased the fusion. Altogether, these data demonstrate that MARCKS prot...Continue Reading

References

Mar 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·J T SeykoraA Aderem
Jul 1, 1991·Physiological Reviews·D E Croall, G N DeMartino
May 1, 1990·Developmental Biology·J D DavidG P Perrot
May 15, 1985·The Biochemical Journal·M J Wakelam
Oct 19, 1995·Nature·T Yagami-HiromasaA Fujisawa-Sehara
Sep 20, 1997·The Journal of Biological Chemistry·G Spizz, P J Blackshear
Mar 12, 1998·International Journal of Cancer. Journal International Du Cancer·Y YokoyamaT Ohnuma
Feb 2, 1999·Experimental Cell Research·N DourdinA Ducastaing
Dec 10, 1999·Molecular Biology of the Cell·J C AdamsL Zhang
Jun 8, 2001·The International Journal of Biochemistry & Cell Biology·S PoussardP Cottin
Aug 23, 2001·Trends in Molecular Medicine·Y Huang, K K Wang
Apr 16, 2002·Molecular and Cellular Biochemistry·B AragonP Cottin
Jan 17, 2003·The Journal of Biological Chemistry·Christelle DelmasStéphane Manenti
Apr 4, 2003·The International Journal of Biochemistry & Cell Biology·Lydie CombaretDidier Attaix
Jul 5, 2003·Physiological Reviews·Darrell E GollJinyang Cong
Sep 25, 2003·The Journal of Biological Chemistry·Mamoru MatsubaraNobuihiro Hayashi
Nov 13, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jeanne KwikMichael Edidin
Jan 15, 2004·Experimental Cell Research·Stéphane DedieuJean-Jacques Brustis

❮ Previous
Next ❯

Citations

Dec 1, 2011·Purinergic Signalling·Rosa MancinelliStefania Fulle
Oct 23, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Thomas S MonahanFrank W LoGerfo
Feb 2, 2013·International Journal of Radiation Biology·Roberto IorioRosella Cardigno Colonna
Feb 6, 2013·Expert Opinion on Therapeutic Targets·Michel BaudryXiaoning Bi
Dec 21, 2004·Biochemical and Biophysical Research Communications·Toshiya MatsubaraKatsuya Nagai
Nov 4, 2008·Journal of Molecular and Cellular Cardiology·Kylie VenardosDavid M Kaye
Aug 5, 2009·Experimental Cell Research·Elise DargelosSylvie Poussard
May 5, 2017·American Journal of Physiology. Cell Physiology·Darrice S MontgomeryAbdel A Alli
Aug 4, 2006·The FEBS Journal·Marie-Christine Lebart, Yves Benyamin
Sep 13, 2007·Proteomics·Sébastien GoudenegeSylvie Poussard
Mar 2, 2019·Current Neuropharmacology·Michel Baudry
Mar 31, 2011·Journal of Cellular Physiology·Atsuhiro TanabeYasuharu Sasaki
Nov 3, 2016·The Journal of Veterinary Medical Science·Cuong VAN DaoAtsushi Miyamoto
Nov 13, 2008·Journal of Cell Science·Magali LouisPhilippe Gailly
Sep 1, 2005·Journal of Cell Science·Santos J Franco, Anna Huttenlocher
Nov 22, 2005·The International Journal of Biochemistry & Cell Biology·Fabrice RaynaudBenyamin Yves
Oct 17, 2007·Experimental Gerontology·Elise DargelosPatrick Cottin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.